when will the semaglutide shortage end Wegovy Continues, Leaving Patients On the Weight Loss Drug in Limbo Drug compounders sue FDA over

If its close to your next scheduled dose, skip the missed dose and continue with your regular dosing schedule

Always consult with a qualified healthcare provider before starting any weight loss medication

(Source: NEJM SELECT Trial, 2023) Semaglutide Also Reduces Fatty Liver Disease Risk A 2026 analysis of the SELECT trial found that semaglutide also reduces major heart events and lowers fatty liver disease risk in adults with both obesity and heart disease

Eso s, tambin primando su uso para el control glucmico

In many cases, this is more likely related to rapid weight loss, nutritional changes, or other health factors rather than the medication itself